Literature DB >> 20932482

Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop.

Janos Steffen1, Michael Seeger, Annett Koch, Elke Krüger.   

Abstract

Coordinated regulation of the ubiquitin-proteasome system (UPS) is crucial for the cell to adjust its protein degradation capacity to changing proteolytic requirements. We have shown previously that mammalian cells upregulate proteasome gene expression in response to proteasome inhibition. Here, we report the identification of the transcription factor TCF11 (long isoform of Nrf1) as a key regulator for 26S proteasome formation in human cells to compensate for reduced proteolytic activity. Under noninducing conditions, TCF11 resides in the endoplasmic reticulum (ER) membrane. There, TCF11 is targeted to ER-associated protein degradation requiring the E3 ubiquitin ligase HRD1 and the AAA ATPase p97. Proteasome inhibitors trigger the accumulation of oxidant-damaged proteins and promote the nuclear translocation of TCF11 from the ER, permitting activation of proteasome gene expression by binding to antioxidant response elements in their promoter regions. Thus, we uncovered the transcriptional control loop regulating human proteasome-dependent protein degradation to counteract proteotoxic stress caused by proteasome inhibition.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932482     DOI: 10.1016/j.molcel.2010.09.012

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  151 in total

1.  Inflammatory macrophages induce Nrf2 transcription factor-dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection.

Authors:  Susanne Sebens; Iris Bauer; Claudia Geismann; Evelin Grage-Griebenow; Stefan Ehlers; Marie-Luise Kruse; Alexander Arlt; Heiner Schäfer
Journal:  J Biol Chem       Date:  2011-10-11       Impact factor: 5.157

2.  Live cell imaging of protein dislocation from the endoplasmic reticulum.

Authors:  Yongwang Zhong; Shengyun Fang
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

3.  The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis.

Authors:  Madhurima Biswas; Diane Phan; Momoko Watanabe; Jefferson Y Chan
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

Review 4.  Regulation of proteasome activity in health and disease.

Authors:  Marion Schmidt; Daniel Finley
Journal:  Biochim Biophys Acta       Date:  2013-08-27

5.  Cuz1/Ynl155w, a zinc-dependent ubiquitin-binding protein, protects cells from metalloid-induced proteotoxicity.

Authors:  John Hanna; David Waterman; Marta Isasa; Suzanne Elsasser; Yuan Shi; Steven Gygi; Daniel Finley
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

6.  PARK2/Parkin-mediated mitochondrial clearance contributes to proteasome activation during slow-twitch muscle atrophy via NFE2L1 nuclear translocation.

Authors:  Norihiko Furuya; Shin-Ichi Ikeda; Shigeto Sato; Sanae Soma; Junji Ezaki; Juan Alejandro Oliva Trejo; Mitsue Takeda-Ezaki; Tsutomu Fujimura; Eri Arikawa-Hirasawa; Norihiro Tada; Masaaki Komatsu; Keiji Tanaka; Eiki Kominami; Nobutaka Hattori; Takashi Ueno
Journal:  Autophagy       Date:  2014-01-21       Impact factor: 16.016

Review 7.  Oxidative stress-mediated regulation of proteasome complexes.

Authors:  Charity T Aiken; Robyn M Kaake; Xiaorong Wang; Lan Huang
Journal:  Mol Cell Proteomics       Date:  2011-05       Impact factor: 5.911

8.  Structural defects in the regulatory particle-core particle interface of the proteasome induce a novel proteasome stress response.

Authors:  Soyeon Park; Woong Kim; Geng Tian; Steven P Gygi; Daniel Finley
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

9.  Epidithiodiketopiperazines Inhibit Protein Degradation by Targeting Proteasome Deubiquitinase Rpn11.

Authors:  Jing Li; Yaru Zhang; Bruno Da Silva Sil Dos Santos; Feng Wang; Yuyong Ma; Christian Perez; Yanling Yang; Junmin Peng; Seth M Cohen; Tsui-Fen Chou; Stephen T Hilton; Raymond J Deshaies
Journal:  Cell Chem Biol       Date:  2018-08-23       Impact factor: 8.116

Review 10.  Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy.

Authors:  Michael Basler; Marcus Groettrup
Journal:  Genes Immun       Date:  2020-08-25       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.